PRaG Therapy of Refractory Metastatic Gastric Cancer: A Case Report

Patients with metastatic gastric cancer had limited treatments and often had a somber prognosis, especially when patients were unable to tolerate high-intensity cytotoxic treatment due to poor physical condition or organ dysfunction after the failure of standard therapy. Here, we reported a metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hong, Hong, Zhihui, Xu, Meiling, Kong, Yuehong, Ma, Yifu, Shan, Chanchan, Xing, Pengfei, Zhang, Liyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300850/
https://www.ncbi.nlm.nih.gov/pubmed/35874658
http://dx.doi.org/10.3389/fimmu.2022.926740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300850/
https://www.ncbi.nlm.nih.gov/pubmed/35874658
http://dx.doi.org/10.3389/fimmu.2022.926740

Ejemplares similares